Hydroxyzine Pamoate
Product Images NDC 10544-556

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Hydroxyzine Pamoate (NDC 10544-556). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Blenheim Pharmacal, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

25mg 20ct (Label Hydroxyzine Pamoate Caps 25mg Bpi(10544 556 20) Watson(0591 0800 05) Rev1)

Label of Hydroxyzine Pamoate Capsules USP 25mg by Blenheim Pharmacal, Inc. The label indicates the product contains 20 capsules, is prescription only, and includes storage instructions to keep below 86°F (30°C) in a tight, light-resistant container. The label displays the NDC 10544-556-20 and manufacturing code 0591-0800-05, with dosage directions referring to the package insert.*

FDA Label Image

Structure (Hydroxyzine Pamoate Capsules 1)

Chemical structure diagram showing the molecular formula of Hydroxyzine Pamoate with formulas C21H27ClN2O2 and C23H16O6 as indicated at the bottom of the image.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.